RESEARCH & DEVELOPMENT PROJECTS

globe

Bravo Pharma companies have carried out the following R&D projects:

  • * Identification and characterization of inhibitors of molecular pathways linked to cancer
  • * Mechanism studies and pre-clinical development of novel angiogenesis inhibitor
  • * Cellular immunotherapy
  • * Pre-clinical development of targeted therapy against melanoma
  • * Pre-clinical and clinical development of drug candidate against rare blood cancers
  • * Pre-clinical and clinical studies of combination therapy for hormone sensitive cancers
  • * Bioenergetics of cancer cell
  • * Therapeutic antibodies